Canada Life
ONCE

Canada Life’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Canada Life’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,069
Closed -$416K – 2692
2019
Q2 		$416K Sell
4,069
-1,182
-23% -$128K ﹤0.01% 1826
2019
Q1 		$596K Buy
5,251
+1,312
+33% +$96.4K ﹤0.01% 1579
2018
Q4 		$149K Hold
3,939
– – ﹤0.01% 2014
2018
Q3 		$215K Hold
3,939
– – ﹤0.01% 1962
2018
Q2 		$326K Hold
3,939
– – ﹤0.01% 1839
2018
Q1 		$263K Hold
3,939
– – ﹤0.01% 1883
2017
Q4 		$202K Hold
3,939
– – ﹤0.01% 1961
2017
Q3 		$351K Buy
3,939
+1,264
+47% +$96K ﹤0.01% 1806
2017
Q2 		$159K Hold
2,675
– – ﹤0.01% 1979
2017
Q1 		$142K Hold
2,675
– – ﹤0.01% 2001
2016
Q4 		$134K Hold
2,675
– – ﹤0.01% 2025
2016
Q3 		$160K Buy
2,675
+1,422
+113% +$82K ﹤0.01% 1968
2016
Q2 		$64K Hold
1,253
– – ﹤0.01% 2249
2016
Q1 		$37K Hold
1,253
– – ﹤0.01% 2232
2015
Q4 		$57K Buy
+1,253
New +$65.7K ﹤0.01% 2094

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Canada Life's ONCE Position: Q3 2019 in Review

Canada Life sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2019, closing a stake of 4,069 shares — an estimated $416K sold.

Canada Life first reported a position in ONCE in Q4 2015 and held it in 15 quarters. The position peaked at $596K in Q1 2019. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.

  • Canada Life reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Canada Life sold 4,069 Spark Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $416K.
  • Canada Life first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2015 and held it in 15 quarters.
  • Canada Life's Spark Therapeutics, Inc. Common Stock position peaked at $596K in Q1 2019.
  • 184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Canada Life's 13F filing for Q3 2019, filed 25 Oct 2019.